A new trading day began on Monday, with Immunome Inc (NASDAQ: IMNM) stock price down -3.01% from the previous day of trading, before settling in for the closing price of $12.28. IMNM’s price has ranged from $6.93 to $30.96 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 26.27%. With a float of $48.99 million, this company’s outstanding shares have now reached $60.05 million.
In an organization with 55 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 87.4%, operating margin of -2518.49%, and the pretax margin is -2435.02%.
Immunome Inc (IMNM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immunome Inc is 18.42%, while institutional ownership is 79.05%. The most recent insider transaction that took place on Sep 19 ’24, was worth 230,224. In this transaction Chief Financial Officer of this company sold 14,380 shares at a rate of $16.01, taking the stock ownership to the 47,476 shares. Before that another transaction happened on Sep 19 ’24, when Company’s Officer proposed sale 14,380 for $16.01, making the entire transaction worth $230,211.
Immunome Inc (IMNM) Latest Financial update
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.46 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.27% per share during the next fiscal year.
Immunome Inc (NASDAQ: IMNM) Trading Performance Indicators
Here are Immunome Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 66.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.69, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -2.82 in one year’s time.
Technical Analysis of Immunome Inc (IMNM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.59 million. That was inferior than the volume of 0.78 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 23.38%. Additionally, its Average True Range was 0.73.
During the past 100 days, Immunome Inc’s (IMNM) raw stochastic average was set at 14.63%, which indicates a significant increase from 8.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.88% in the past 14 days, which was lower than the 67.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.02, while its 200-day Moving Average is $16.43. However, in the short run, Immunome Inc’s stock first resistance to watch stands at $12.25. Second resistance stands at $12.58. The third major resistance level sits at $12.81. If the price goes on to break the first support level at $11.69, it is likely to go to the next support level at $11.46. The third support level lies at $11.13 if the price breaches the second support level.
Immunome Inc (NASDAQ: IMNM) Key Stats
With a market capitalization of 715.20 million, the company has a total of 59,969K Shares Outstanding. Currently, annual sales are 14,020 K while annual income is -106,810 K. The company’s previous quarter sales were 2,360 K while its latest quarter income was -36,120 K.
